These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7060816)

  • 41. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hysterosalpingographic changes due to long term effect of intrauterine device.
    Achari K; Kundra VL
    J Obstet Gynaecol India; 1974 Jun; 24(3):293-7. PubMed ID: 12156553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered ciliary substructure in the endosalpinx in women using an IUCD.
    Wollen AL; Flood PR; Sandvei R
    Acta Obstet Gynecol Scand; 1990; 69(4):307-12. PubMed ID: 2244462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vesico-ovarian fistula in suppurative ovarian inflammation and salpingitis.
    Carl P
    J Urol; 1990 Feb; 143(2):352-3. PubMed ID: 2299729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The intrauterine device, pelvic inflammatory disease, and infertility: the confusion between hypothesis and knowledge.
    Grimes DA
    Fertil Steril; 1992 Oct; 58(4):670-3. PubMed ID: 1426307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of endometriosis in women attending family planning clinics.
    Vessey MP; Villard-Mackintosh L; Painter R
    BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Attitudes towards contraception and some reasons for discontinuation].
    Lodewijckx E
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1025-30. PubMed ID: 12341566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory disease with use of IUD.
    Fribourg S
    Am J Obstet Gynecol; 1981 Sep; 141(1):112-3. PubMed ID: 7270616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Lippes loop on sperm recovery from human fallopian tubes.
    El-Habashi M; El-Sahwi S; Gawish S; Osman M
    Contraception; 1980 Nov; 22(5):549-55. PubMed ID: 7471742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuboovarian abscess and the intrauterine device (Majzlin Spring).
    Duckman S; Suarez J; Tantakesem P
    Am J Obstet Gynecol; 1973 Apr; 115(8):1157-8. PubMed ID: 4691475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The acceptability of current contraceptive methods to adolescents].
    Sotnikova EI; Dubnitskaia LV; Perminova SG
    Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New insights on the mode of action of intrauterine contraceptive devices in women.
    Alvarez F; Brache V; Fernandez E; Guerrero B; Guiloff E; Hess R; Salvatierra AM; Zacharias S
    Fertil Steril; 1988 May; 49(5):768-73. PubMed ID: 3360166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.